On 2025-05-12, Mineralys Therapeutics, Inc. (MLYS) announced earnings per share of $-0.79 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-1.02.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.86 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $-1.02 | $-0.79 |
| 2025-02-12 | 2024-12-31 | $-1.00 | $-0.98 |
| 2024-11-11 | 2024-09-30 | $-0.83 | $-1.13 |
| 2024-08-13 | 2024-06-30 | $-0.73 | $-0.83 |
| 2024-05-09 | 2024-03-31 | $-0.68 | $-0.70 |
| 2024-03-21 | 2023-12-31 | $-0.85 | $-0.61 |
| 2023-11-07 | 2023-09-30 | $-0.72 | $-0.57 |
| 2023-08-07 | 2023-06-30 | $-0.83 | $-0.31 |
| 2023-05-15 | 2023-03-31 | $-0.71 | $-0.51 |
| 2023-03-15 | 2022-12-31 | -- | $-1.74 |